Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$376K Sell
3,122
-18
-0.6% -$2.08K 0.18% 105
2025
Q4
$331K Buy
3,140
+303
+11% +$28.4K 0.21% 102
2025
Q3
$238K Hold
2,837
0.12% 134
2025
Q2
$225K Buy
2,837
+423
+18% +$33.6K 0.12% 141
2025
Q1
$217K Sell
2,414
-350
-13% -$32.7K 0.12% 132
2024
Q4
$275K Buy
+2,764
New +$285K 0.14% 125

Other funds holding MRK

ELCO Management's MRK Position: Q1 2026 in Review

ELCO Management reduced its Merck (MRK) stake by 0.57% in Q1 2026, selling an estimated $2.08K and leaving 3,122 shares worth $376K. The position accounts for 0.18% of the portfolio, ranked #105.

ELCO Management first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • ELCO Management held 3,122 shares of Merck worth $376K as of Q1 2026.
  • ELCO Management sold 18 Merck shares in Q1 2026, an estimated $2.08K.
  • Merck made up 0.18% of ELCO Management's portfolio in Q1 2026, its #105 holding.
  • ELCO Management first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on ELCO Management's 13F filing for Q1 2026, filed 24 Apr 2026.